Colchicine use in patients with COVID-19: A systematic review and meta-analysis.

Leonard ChiuChun-Han LoMax ShenNicholas ChiuRahul AggarwalJihui LeeYoung-Geun ChoiHenry LamElizabeth Horn PrsicRonald ChowHyun Joon Shin

Published in: PloS one (2021)

Colchicine may reduce the risk of mortality in individuals with COVID-19. Further prospective investigation may further determine the efficacy of colchicine as treatment in COVID-19 patients in various care settings of the disease, including post-hospitalization and long-term care.

Keyphrases

long term care
sars cov
coronavirus disease
healthcare
palliative care
cardiovascular events
risk factors
cardiovascular disease
type diabetes
combination therapy
replacement therapy
affordable care act